Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study
Resource Type
Article
Authors
Goepfert, Paul A ; Fu, Bo ; Chabanon, Anne-Laure ; Bonaparte, Matthew I ; Davis, Matthew G ; Essink, Brandon J ; Frank, Ian ; Haney, Owen ; Janosczyk, Helene ; Keefer, Michael C ; Koutsoukos, Marguerite ; Kimmel, Murray A ; Masotti, Roger ; Savarino, Stephen J ; Schuerman, Lode ; Schwartz, Howard ; Sher, Lawrence D ; Smith, Jon ; Tavares-Da-Silva, Fernanda ; Gurunathan, Sanjay ; DiazGranados, Carlos A ; de Bruyn, Guy
Source
In The Lancet Infectious Diseases September 2021 21(9):1257-1270
Subject
Primary Research Articles
Language
ISSN
1473-3099